• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自身免疫相关甲状腺疾病的综合研究:自身免疫性甲状腺疾病、免疫检查点抑制剂治疗期间的甲状腺疾病和免疫球蛋白 G4 相关甲状腺疾病。

Comprehensive research on thyroid diseases associated with autoimmunity: autoimmune thyroid diseases, thyroid diseases during immune-checkpoint inhibitors therapy, and immunoglobulin-G4-associated thyroid diseases.

机构信息

The First Department of Medicine, Wakayama Medical University, Wakayama, 641-8509, Japan.

出版信息

Endocr J. 2019 Oct 28;66(10):843-852. doi: 10.1507/endocrj.EJ19-0234. Epub 2019 Aug 20.

DOI:10.1507/endocrj.EJ19-0234
PMID:31434818
Abstract

Various thyroid diseases are associated with autoimmunity. Major autoimmune thyroid diseases are Graves' disease (GD) and Hashimoto's thyroiditis (HT). Thyrotropin receptor is an autoantigen in GD, and its immunogenicity has been examined. Immune-checkpoint inhibitor (ICI) is recently widely used for treatment of malignant tumors, but cases of thyroid diseases during ICI treatment have been increasing. Thyroid diseases during ICI therapy have been investigated in immunological and clinical aspects, and their Japanese official diagnostic guidelines were established. In addition, serum and tissue immunoglobulin-G4 levels have been examined in association with clinicopathological characteristics in GD, HT, and Riedel's thyroiditis. We review these diseases associated with thyroid autoimmunity and comprehensively discuss their potential application in future research and therapeutic options.

摘要

各种甲状腺疾病都与自身免疫有关。主要的自身免疫性甲状腺疾病有格雷夫斯病(GD)和桥本甲状腺炎(HT)。促甲状腺素受体是 GD 中的一种自身抗原,其免疫原性已被研究。免疫检查点抑制剂(ICI)最近被广泛用于治疗恶性肿瘤,但在 ICI 治疗期间甲状腺疾病的病例越来越多。ICI 治疗期间的甲状腺疾病在免疫学和临床方面进行了研究,并制定了其日本官方诊断指南。此外,还对 GD、HT 和 Riedel 甲状腺炎中的血清和组织免疫球蛋白-G4 水平与临床病理特征进行了检查。我们综述了与甲状腺自身免疫相关的这些疾病,并全面讨论了它们在未来研究和治疗选择中的潜在应用。

相似文献

1
Comprehensive research on thyroid diseases associated with autoimmunity: autoimmune thyroid diseases, thyroid diseases during immune-checkpoint inhibitors therapy, and immunoglobulin-G4-associated thyroid diseases.自身免疫相关甲状腺疾病的综合研究:自身免疫性甲状腺疾病、免疫检查点抑制剂治疗期间的甲状腺疾病和免疫球蛋白 G4 相关甲状腺疾病。
Endocr J. 2019 Oct 28;66(10):843-852. doi: 10.1507/endocrj.EJ19-0234. Epub 2019 Aug 20.
2
Thyrotropin-receptor and thyroid peroxidase-specific T cell clones and their cytokine profile in autoimmune thyroid disease.自身免疫性甲状腺疾病中促甲状腺激素受体和甲状腺过氧化物酶特异性T细胞克隆及其细胞因子谱
J Clin Endocrinol Metab. 1997 Nov;82(11):3655-63. doi: 10.1210/jcem.82.11.4336.
3
Autoimmunity of thyroid disease. With emphasis on Graves' disease.甲状腺疾病的自身免疫性。重点论述格雷夫斯病。
Neth J Med. 1985;28(1):32-9.
4
The pathogenesis of thyroid autoimmune diseases: New T lymphocytes - Cytokines circuits beyond the Th1-Th2 paradigm.甲状腺自身免疫性疾病的发病机制:新的 T 淋巴细胞-细胞因子回路超越 Th1-Th2 范式。
J Cell Physiol. 2019 Mar;234(3):2204-2216. doi: 10.1002/jcp.27180. Epub 2018 Sep 24.
5
[The role of hereditary and environmental factors in autoimmune thyroid diseases].[遗传和环境因素在自身免疫性甲状腺疾病中的作用]
Orv Hetil. 2012 Jul 1;153(26):1013-22. doi: 10.1556/OH.2012.29370.
6
Changes of IgG -Glycosylation in Thyroid Autoimmunity: The Modulatory Effect of Methimazole in Graves' Disease and the Association With the Severity of Inflammation in Hashimoto's Thyroiditis.甲状腺自身免疫中 IgG-糖基化的变化:甲巯咪唑在格雷夫斯病中的调节作用及与桥本甲状腺炎炎症严重程度的关系。
Front Immunol. 2022 Mar 15;13:841710. doi: 10.3389/fimmu.2022.841710. eCollection 2022.
7
Autoimmune and non-autoimmune thyroid diseases have different patterns of cellular HLA class II expression.自身免疫性和非自身免疫性甲状腺疾病具有不同的细胞 HLA 二类分子表达模式。
Sao Paulo Med J. 1999 Jul 1;117(4):161-4. doi: 10.1590/s1516-31801999000400004.
8
Patterns of cellular immune responses to thyrocyte membrane antigens and specific immunoregulatory defects in autoimmune thyroid disease.自身免疫性甲状腺疾病中针对甲状腺细胞膜抗原的细胞免疫反应模式及特异性免疫调节缺陷
J Clin Lab Immunol. 1990 Jul;32(3):103-8.
9
[Significance of circulating anti-thyroid stimulating hormone (TSH) receptor antibodies in patients with autoimmune thyroid diseases--thyroid stimulation blocking antibody in patients with Graves' disease].[自身免疫性甲状腺疾病患者循环抗促甲状腺激素(TSH)受体抗体的意义——格雷夫斯病患者的甲状腺刺激阻断抗体]
J UOEH. 1989 Dec 1;11(4):393-401. doi: 10.7888/juoeh.11.393.
10
Immunologic aspects of thyroid disease.甲状腺疾病的免疫学方面。
Ophthalmology. 1981 Jun;88(6):471-5. doi: 10.1016/s0161-6420(81)35002-7.

引用本文的文献

1
Pembrolizumab-Induced Thyroid Storm in a Patient With Triple-Negative Breast Cancer.帕博利珠单抗诱发三阴性乳腺癌患者甲状腺危象
AACE Endocrinol Diabetes. 2025 May 2;12(2):107-111. doi: 10.1016/j.aed.2025.04.008. eCollection 2025 Jul-Aug.
2
Interpretable machine learning model predicting immune checkpoint inhibitor-induced hypothyroidism: A retrospective cohort study.可解释机器学习模型预测免疫检查点抑制剂诱导的甲状腺功能减退症:一项回顾性队列研究。
Cancer Sci. 2024 Nov;115(11):3767-3775. doi: 10.1111/cas.16352. Epub 2024 Sep 23.
3
Reshaping the Concept of Riedel's Thyroiditis into the Larger Frame of IgG4-Related Disease (Spectrum of IgG4-Related Thyroid Disease).
将里德耳甲状腺炎的概念重塑为IgG4相关疾病(IgG4相关甲状腺疾病谱)这一更大范畴。
Biomedicines. 2023 Jun 11;11(6):1691. doi: 10.3390/biomedicines11061691.
4
Amino acid polymorphisms in human histocompatibility leukocyte antigen class II and proinsulin epitope have impacts on type 1 diabetes mellitus induced by immune-checkpoint inhibitors.人类组织相容性白细胞抗原 II 类和胰岛素原表位中的氨基酸多态性对免疫检查点抑制剂诱导的 1 型糖尿病有影响。
Front Immunol. 2023 Apr 6;14:1165004. doi: 10.3389/fimmu.2023.1165004. eCollection 2023.
5
Durvalumab-induced thyroiditis in a patient with non-small cell lung carcinoma: a case report and review of pathogenic mechanisms.度伐利尤单抗致非小细胞肺癌患者甲状腺炎:病例报告及发病机制探讨。
BMC Endocr Disord. 2022 Nov 22;22(1):291. doi: 10.1186/s12902-022-01190-5.
6
Thyroid-related adverse events induced by immune checkpoint inhibitors.免疫检查点抑制剂引起的甲状腺相关不良事件。
Front Endocrinol (Lausanne). 2022 Sep 20;13:1010279. doi: 10.3389/fendo.2022.1010279. eCollection 2022.
7
Human Leukocyte Antigens and Biomarkers in Type 1 Diabetes Mellitus Induced by Immune-Checkpoint Inhibitors.免疫检查点抑制剂诱导的 1 型糖尿病中的人类白细胞抗原和生物标志物。
Endocrinol Metab (Seoul). 2022 Feb;37(1):84-95. doi: 10.3803/EnM.2021.1282. Epub 2022 Feb 28.
8
Safety and efficacy of CAR T cells in a patient with lymphoma and a coexisting autoimmune neuropathy.CAR T 细胞治疗伴有共存自身免疫性神经病的淋巴瘤患者的安全性和有效性。
Blood Adv. 2020 Dec 8;4(23):6019-6022. doi: 10.1182/bloodadvances.2020003176.
9
The Value of Strain Elastography in Predicting Autoimmune Thyroiditis.应变弹性成像在预测自身免疫性甲状腺炎中的价值。
Diagnostics (Basel). 2020 Oct 27;10(11):874. doi: 10.3390/diagnostics10110874.
10
Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune-checkpoint inhibitors.预测和敏感的生物标志物,用于免疫检查点抑制剂治疗期间的甲状腺功能障碍。
Cancer Sci. 2020 May;111(5):1468-1477. doi: 10.1111/cas.14363. Epub 2020 Mar 17.